Cheshire, UK--(Marketwire - November 19, 2007) -
Protherics PLC
Notification of Major Interests in Shares
London, UK; Brentwood, TN, US: 19 November 2007 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that on 16 November 2007, in accordance with the Transparency Obligations Directive, a notification of interest in the ordinary share capital of the Company was received from AXA Investment Managers UK Limited on behalf of AXA S.A. and its Group Companies ("AXA"). The notification follows an increase in the Indirect holding of AXA. Details of the interest notified are as follows:
1. Reason for the notification (please tick the appropriate box or boxes)
A acquisition of voting rights x
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights
Other (please specify):
2. Full name of person(s) subject to the AXA S.A., 25 Avenue Matignon,
notification obligation: 75008 Paris and its
group of companies.
3. Full name of shareholder(s) (if different
from 2.):
4. Date of the transaction (and date on which 15 November 2007
the threshold is crossed or reached if
different):
5. Date on which issuer notified: 16 November 2007
6. Threshold(s) that is/are crossed or
reached: 12%
7. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the
shares the Triggering triggering transaction
transaction
if possible using Number of Number of Number of Number of
the ISIN CODE Shares of voting shares voting rights
Rights Direct Direct Indirect
0702920 41,452,836 41,452,836 741,666 741,666 41,034,072
% of voting rights
Direct Indirect
0.22% 12.09%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Exercise/ Conversion Number of % of
instrument Period/ Date voting rights voting
that may be acquired rights
Expiration if the instrument
date is exercised/
converted.
Total (A+B)
Number of voting rights % of voting rights
41,775,738 12.31%
8. Chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held, if applicable:
Name of Company/Fund Number % of issued
of Shares share capital
AXA UK Investment Co ICVC 538,641 0.15873
UK Smaller Companies Fund
Indirect
Sun Life Pensions Management Ltd 25,000 0.00737
Direct
AXA Sun Life 53,913 0.01589
FTSE All Share Tracker Life
Direct
AXA Sun Life 294,874 0.08689
FTSE All Share Tracker Pension
Direct
AXA Framlington 750,000 0.22101
SEI UK Equity
Indirect
AXA Framlington 972,006 0.28643
St James Place Exempt (Pens) Fund
Indirect
AXA Framlington 1,093,505 0.32224
St James Place Net (Life) Fund
Indirect
AXA Framlington 243,001 0.07161
St James Place Offshore Fund
Indirect
AXA Framlington 364,502 0.10741
Daimler Chrysler
Indirect
AXA Framlington 3,120,333 0.91951
Throgmorton Trust
Indirect
AXA Framlington 15,013,453 4.42422
UK Selet Ops
Indirect
AXA Framlington 13,753,131 4.05282
Equity Income
Indirect
AXA Framlington 2,000,000 0.58937
Managed Balanced
Indirect
AXA Framlington 1,500,000 0.44203
UK Smaller Companies
Indirect
AXA Framlington 500,000 0.14734
BAE Systems Pensions Fund CIF Trustees
Indirect
AXA Framlington 220,000 0.06483
BAE Systems 2000 Pensions Fund
Indirect
AXA Framlington onshore private clients 850,500 0.25063
Indirect
AXA Framlington 115,000 0.03389
St James Place Internal Equity & Income UT
Indirect
Axa Sun Life with Profits Passive 226,817 0.06684
Direct
Sun Life Ass Soc with Profits Passive 141,062 0.04157
Direct
Total Direct 741,666 0.21856
Total Indirect 41,034,072 12.09207
TOTAL 41,775,738 12.31063
Proxy Voting:
9. Name of the proxy holder:
10. Number of voting rights proxy holder will cease to hold:
11. Date on which proxy holder will cease to hold voting
rights:
12. Additional information:
| Ends |
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange